SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-14-006474
Filing Date
2014-09-09
Accepted
2014-09-09 07:56:57
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10kt2014_relmadatherapeutic.htm 10-KT 1891341
2 SUBSIDIARIES f10kt2014ex21i_relmada.htm EX-21.1 928
3 CERTIFICATION f10kt2014ex31i_relmada.htm EX-31.1 11598
4 CERTIFICATION f10kt2014ex31ii_relmada.htm EX-31.2 11212
5 CERTIFICATION f10kt2014ex32i_relmada.htm EX-32.1 6170
6 CERTIFICATION f10kt2014ex32ii_relmada.htm EX-32.2 6377
  Complete submission text file 0001213900-14-006474.txt   8865926

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE relm-20140630.xml EX-101.INS 1269170
8 XBRL SCHEMA FILE relm-20140630.xsd EX-101.SCH 64805
9 XBRL CALCULATION FILE relm-20140630_cal.xml EX-101.CAL 35445
10 XBRL DEFINITION FILE relm-20140630_def.xml EX-101.DEF 271712
11 XBRL LABEL FILE relm-20140630_lab.xml EX-101.LAB 537518
12 XBRL PRESENTATION FILE relm-20140630_pre.xml EX-101.PRE 395187
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-KT | Act: 34 | File No.: 333-184881 | Film No.: 141092348
SIC: 2834 Pharmaceutical Preparations